64 results
Page 3 of 4
8-K
EX-99.1
ys2jwivtoibrx 2ow
10 Aug 22
TScan Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Progress
12:00am
8-K
9b5j j4m2t42lxb
7 Jul 22
Departure of Directors or Certain Officers
7:11am
8-K
EX-99.1
nmal31ig9zm qc
31 May 22
TScan Therapeutics Announces FDA Clearance of Investigational New Drug Application for TSC-101 for the Treatment of Hematologic Malignancies
7:07am
8-K
EX-99.1
5a9g8ef1ybalch3
9 May 22
TScan Therapeutics Reports First Quarter 2022 Financial Results and Upcoming Anticipated Milestones
7:08am
DEF 14A
3zyqnw
21 Apr 22
Definitive proxy
8:00am
10-K
b63tco6
9 Mar 22
Annual report
7:30am
8-K
EX-99.1
aggup
10 Nov 21
TScan Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Company Progress
7:02am
10-Q
akgv9goj
19 Aug 21
Quarterly report
7:31am
8-K
EX-99.1
ihxtf89oa2 sf
19 Aug 21
TScan Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Recent Company Progress
7:15am
424B4
d1ghjz
19 Jul 21
Prospectus supplement with pricing info
7:01am
S-1/A
z3ayo2
30 Apr 21
IPO registration (amended)
5:00pm
S-1
EX-10.18
2j0oa
23 Apr 21
IPO registration
5:15pm
S-1
EX-10.17
t2kcd06si8j1fvvvuc7
23 Apr 21
IPO registration
5:15pm